A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Fibrinolysis
Fibrinolysis is a normal body process that keeps naturally occurring blood clots from growing and causing problems.
Primary fibrinolysis refers to the normal breakdown of clots.
Secondary fibrinolysis is the breakdown of blood clots due to a medical disorder, medicine, or other cause.
Blood clots form on a protein called fibrin. The breakdown of fibrin (fibrinolysis) can increase under certain conditions, such as:
In some situations, doctors may wish to speed up the rate of fibrinolysis. For example, when an abnormal clot forms in the blood vessels of the heart and results in a heart attack, human-made fibrinolytic substances (such as tPA, streptokinase, or Retavase) may be given to break up the clot.
Schafer AI. Hemorrhagic disorders: Disseminated intravascular coagulation, liver failure, and vitamin K deficiency. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 181.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885